LEXX Lexaria Bioscience Corp.
Healthcare · Market cap: $110.1M
–
Bought and sold by quarter, last 5 years
Open-market purchases and sales by this company's insiders, in dollars, last 5 years
| Quarter | Bought | Sold |
|---|---|---|
| 2022-Q1 | $0 | $0 |
| 2022-Q2 | $0 | $0 |
| 2022-Q3 | $0 | $0 |
| 2022-Q4 | $78.7K | $0 |
| 2023-Q1 | $4.3K | $0 |
| 2023-Q2 | $0 | $0 |
| 2023-Q3 | $0 | $0 |
| 2023-Q4 | $0 | $0 |
| 2024-Q1 | $0 | $0 |
| 2024-Q2 | $0 | $0 |
| 2024-Q3 | $5.0K | $10.3K |
| 2024-Q4 | $118.2K | $0 |
| 2025-Q1 | $0 | $0 |
| 2025-Q2 | $0 | $0 |
| 2025-Q3 | $49.1K | $0 |
| 2025-Q4 | $0 | $0 |
| 2026-Q1 | $0 | $0 |
| 2026-Q2 | $0 | $0 |
| 2026-Q3 | $0 | $0 |
| 2026-Q4 | $0 | $0 |
Bought$255.3K13 buy days
Sold$10.3K1 sell day
Net insider flow+$245.0Knet buying · 5 years
Latest trade2025-07-30BUNKA CHRISTOPHER
| Date | Side | Insider | Role | Shares | Avg price | Value | Trades |
|---|---|---|---|---|---|---|---|
| 2025-07-30 | Buy | BUNKA CHRISTOPHER | Director | 11,900 | $0.91 | $10.8K | 1 |
| 2025-07-29 | Buy | BUNKA CHRISTOPHER | Director | 15,600 | $0.92 | $14.4K | 1 |
| 2025-07-29 | Buy | CHRISTOPHER RICHARD | CEO | 15,000 | $0.91 | $13.6K | 1 |
| 2025-07-29 | Buy | DOCHERTY JOHN MARTIN | President | 5,376 | $0.93 | $5.0K | 1 |
| 2025-07-29 | Buy | McKechnie William Edward | Director | 5,000 | $0.91 | $4.6K | 1 |
| 2025-07-29 | Buy | Carle Vanessa | General counsel | 750 | $0.91 | $682 | 1 |
| 2024-12-03 | Buy | CHRISTOPHER RICHARD | CEO | 27,172 | $2.47 | $67.1K | 1 |
| 2024-12-02 | Buy | CHRISTOPHER RICHARD | CEO | 22,828 | $2.24 | $51.1K | 1 |
| 2024-08-12 | Buy | TURKEL CATHERINE C. | Director | 1,600 | $3.13 | $5.0K | 1 |
| 2024-07-31 | Sell | Carle Vanessa | General counsel | 2,567 | $4.00 | $10.3K | 1 |
| 2023-02-09 | Buy | TURKEL CATHERINE C. | Director | 1,500 | $2.84 | $4.3K | 1 |
| 2022-10-14 | Buy | Downey Gregory | CFO | 121 | $2.09 | $253 | 1 |
| 2022-10-13 | Buy | BUNKA CHRISTOPHER | CEO | 16,600 | $2.10 | $34.9K | 1 |
| 2022-10-12 | Buy | BUNKA CHRISTOPHER | CEO | 21,900 | $1.99 | $43.6K | 1 |
Who the insiders are, last 5 years
Everyone who bought or sold this company's shares on the open market in the last 5 years, biggest first.
| Insider | Role | Bought | Sold | Last trade |
|---|---|---|---|---|
| CHRISTOPHER RICHARD | CEO | $131.9K | $0 | 2025-07-29 |
| BUNKA CHRISTOPHER | Director | $103.6K | $0 | 2025-07-30 |
| Carle Vanessa | General counsel | $682 | $10.3K | 2025-07-29 |
| TURKEL CATHERINE C. | Director | $9.3K | $0 | 2024-08-12 |
| DOCHERTY JOHN MARTIN | President | $5.0K | $0 | 2025-07-29 |
| McKechnie William Edward | Director | $4.6K | $0 | 2025-07-29 |
| Downey Gregory | CFO | $253 | $0 | 2022-10-14 |
Past buying clusters
A cluster is a run of purchases by three or more insiders. Returns are the stock's return minus its benchmark's (IWM for small companies, SPY otherwise), from the first open after the run became a cluster. Past results, not a forecast.
| Window | Insiders | Total | Score | 21 days vs benchmark | 63 days vs benchmark | 126 days vs benchmark | Status |
|---|---|---|---|---|---|---|---|
| 2025-07-29 → 2025-07-30 | 5 | $49.1K | 51 | -11.0% (-4.3% raw) | -8.0% (+4.3% raw) | -33.3% (-14.8% raw) | closed |
Yahoo Finance data, delayed, loaded through this server. Informational only; not investment advice.